Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 94-106 , April 2010

Adaptive Radiotherapy for Lung Cancer

  • Jan-Jakob Sonke, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jan-Jakob Sonke, PhD, Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • José Belderbos, MD, PhD

References 

  1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer. Cochrane Database Syst Rev. 2000;CD002139
  2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, in IARC CancerBase. Lyon, France: IARC Press; 2004;
  3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  4. Martel MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer. 1999;24:31–37
  5. Mehta M, Scrimger R, Mackie R, et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2001;49:23–33
  6. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–333
  7. Belderbos JS, Heemsbergen WD, De Jaeger K, et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:126–134
  8. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med. 1992;326:524–530
  9. Auperin A, Rolland E, Curran W, et al. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs): A1-05. J Thorac Oncol. 2007;2:S310
  10. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  11. Martel MK, Ten Haken RK, Hazuka MB, et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 1994;28:575–581
  12. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1–9
  13. Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:672–682
  14. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:318–328
  15. Belderbos J, Heemsbergen W, Hoogeman M, et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol. 2005;75:157–164
  16. Chapet O, Fraass BA, Ten Haken RK. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys. 2006;65:255–265
  17. Bradley J, Deasy JO, Bentzen S, et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:1106–1113
  18. Grills IS, Yan D, Martinez AA, et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys. 2003;57:875–890
  19. Chapet O, Kong FM, Lee JS, et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 2005;77:176–181
  20. Schwarz M, Alber M, Lebesque JV, et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005;62:561–570
  21. van Herk M, Remeijer P, Rasch C, et al. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121–1135
  22. Erridge SC, Seppenwoolde Y, Muller SH, et al. Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol. 2003;66:75–85
  23. Jaffray DA, Siewerdsen JH, Wong JW, et al. Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53:1337–1349
  24. Pouliot J, Bani-Hashemi A, Chen J, et al. Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys. 2005;61:552–560
  25. Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol. 1999;9:108–117
  26. Bijhold J, Lebesque JV, Hart AA, et al. Maximizing setup accuracy using portal images as applied to a conformal boost technique for prostatic cancer. Radiother Oncol. 1992;24:261–271
  27. Leong J. Implementation of random positioning error in computerised radiation treatment planning systems as a result of fractionation. Phys Med Biol. 1987;32:327–334
  28. Valley JF, Mirimanoff RO. Comparison of treatment techniques for lung cancer. Radiother Oncol. 1993;28:168–173
  29. Ketting CH, Austin-Seymour M, Kalet I, et al. Automated planning target volume generation: An evaluation pitting a computer-based tool against human experts. Int J Radiat Oncol Biol Phys. 1997;37:697–704
  30. Steenbakkers RJ, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys. 2006;64:435–448
  31. Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–1024
  32. Grills IS, Fitch DL, Goldstein NS, et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:334–341
  33. Stroom J, Blaauwgeers H, van Baardwijk A, et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. Int J Radiat Oncol Biol Phys. 2007;69:267–275
  34. Marks LB. A standard dose of radiation for “microscopic disease” is not appropriate. Cancer. 1990;66:2498–2502
  35. Withers HR, Peters LJ, Taylor JM. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys. 1995;31:353–359
  36. Ekberg L, Holmberg O, Wittgren L, et al. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?. Radiother Oncol. 1998;48:71–77
  37. de Boer HC, van Sornsen de Koste JR, et al. Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planning. Int J Radiat Oncol Biol Phys. 2001;49:857–868
  38. Borst GR, Sonke JJ, Betgen A, et al. Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. Int J Radiat Oncol Biol Phys. 2007;68:555–561
  39. Purdie TG, Bissonnette JP, Franks K, et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys. 2007;68:243–252
  40. Sonke JJ, Rossi M, Wolthaus J, et al. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys. 2009;74:567–574
  41. Ross CS, Hussey DH, Pennington EC, et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. Int J Radiat Oncol Biol Phys. 1990;18:671–677
  42. Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53:822–834
  43. Pantarotto JR, Piet AH, Vincent A, et al. Motion Analysis of 100 mediastinal lymph nodes: Potential pitfalls in treatment planning and adaptive strategies. Int J Radiat Oncol Biol Phys. 2009;74:1092–1099
  44. Balter JM, Ten Haken RK, Lawrence TS, et al. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. Int J Radiat Oncol Biol Phys. 1996;36:167–174
  45. Nehmeh SA, Erdi YE. Respiratory motion in positron emission tomography/computed tomography: A review. Semin Nucl Med. 2008;38:167–176
  46. Engelsman M, Damen EM, De Jaeger K, et al. The effect of breathing and set-up errors on the cumulative dose to a lung tumor. Radiother Oncol. 2001;60:95–105
  47. Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol. 2000;57:225–236
  48. Chang J, Mageras GS, Yorke E, et al. Observation of interfractional variations in lung tumor position using respiratory gated and ungated megavoltage cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2007;67:1548–1558
  49. Hugo GD, Yan D, Liang J. Population and patient-specific target margins for 4D adaptive radiotherapy to account for intra- and inter-fraction variation in lung tumour position. Phys Med Biol. 2007;52:257–274
  50. Sonke JJ, Lebesque J, van Herk M. Variability of four-dimensional computed tomography patient models. Int J Radiat Oncol Biol Phys. 2008;70:590–598
  51. Hugo G, Vargas C, Liang J, et al. Changes in the respiratory pattern during radiotherapy for cancer in the lung. Radiother Oncol. 2006;78:326–331
  52. Purdie TG, Moseley DJ, Bissonnette JP, et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in stereotactic lung radiation therapy. Acta Oncol. 2006;45:915–922
  53. Ford EC, Mageras GS, Yorke E, et al. Respiration-correlated spiral CT: A method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med Phys. 2003;30:88–97
  54. Vedam SS, Keall PJ, Kini VR, et al. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol. 2003;48:45–62
  55. Low DA, Nystrom M, Kalinin E, et al. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing. Med Phys. 2003;30:1254–1263
  56. Sonke JJ, Zijp L, Remeijer P, et al. Respiratory correlated cone beam CT. Med Phys. 2005;32:1176–1186
  57. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys. 2006;33:3874–3900
  58. Li T, Koong A, Xing L. Enhanced 4D cone-beam CT with inter-phase motion model. Med Phys. 2007;34:3688–3695
  59. Zeng R, Fessler JA, Balter JM. Estimating 3-D respiratory motion from orbiting views by tomographic image registration. IEEE Trans Med Imaging. 2007;26:153–163
  60. Wolthaus JW, Sonke JJ, van Herk M, et al. Reconstruction of a time-averaged midposition CT scan for radiotherapy planning of lung cancer patients using deformable registration. Med Phys. 2008;35:3998–4011
  61. Rit S, Wolthaus JW, van Herk M, et al. On-the-fly motion-compensated cone-beam CT using an a priori model of the respiratory motion. Med Phys. 2009;36:2283–2296
  62. Wolthaus JW, Schneider C, Sonke JJ, et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys. 2006;65:1560–1571
  63. International Commission on Radiation Units and Measurements. ICRU Report 50 (Prescribing, recording and reporting photo beam therapy). Bethesda, MD: International Commission on Radiation Units and Measurements; 1993;
  64. International Commission on Radiation Units and Measurements. ICRU Report 62 (Prescribing, recording and reporting photo beam therapy (supplement to ICRU Report 50)). Bethesda, MD: International Commission on Radiation Units and Measurements; 1999;
  65. Antolak JA, Rosen CCH, Childress CH, et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 1998;42:661–672
  66. Stroom JC, Koper PC, Korevaar GA, et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol. 1999;51:237–248
  67. Craig T, Battista J, Moiseenko V, et al. Considerations for the implementation of target volume protocols in radiation therapy. Int J Radiat Oncol Biol Phys. 2001;49:241–250
  68. Miller RC, Bonner JA, Kline RW. Impact of beam energy and field margin on penumbra at lung tumor-lung parenchyma interfaces. Int J Radiat Oncol Biol Phys. 1998;41:707–713
  69. Aaltonen P, Brahme A, Lax I, et al. Specification of dose delivery in radiation therapy (Recommendation by the Nordic Association of Clinical Physics (NACP)). Acta Oncol. 1997;36(suppl 10):1–32
  70. Allen AM, Siracuse KM, Hayman JA, et al. Evaluation of the influence of breathing on the movement and modeling of lung tumors. Int J Radiat Oncol Biol Phys. 2004;58:1251–1257
  71. Shih HA, Jiang SB, Aljarrah KM, et al. Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:613–622
  72. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:253–260
  73. Rietzel E, Liu AK, Chen GT, et al. Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning. Int J Radiat Oncol Biol Phys. 2008;71:1245–1252
  74. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys. 2005;62:554–560
  75. Lujan AE, Larsen EW, Balter JM, et al. A method for incorporating organ motion due to breathing into 3D dose calculations. Med Phys. 1999;26:715–720
  76. McKenzie AL. How should breathing motion be combined with other errors when drawing margins around clinical target volumes?. Br J Radiol. 2000;73:973–977
  77. Harsolia A, Hugo GD, Kestin LL, et al. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2008;70:582–589
  78. Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1268–1279
  79. Li JG, Xing L. Inverse planning incorporating organ motion. Med Phys. 2000;27:1573–1578
  80. Engelsman M, Remeijer P, van Herk M, et al. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer. Med Phys. 2003;30:1086–1095
  81. Zhang T, Jeraj R, Keller H, et al. Treatment plan optimization incorporating respiratory motion. Med Phys. 2004;31:1576–1586
  82. Chetty IJ, Rosu M, McShan DL, et al. Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys. 2004;31:925–932
  83. Trofimov A, Rietzel E, Lu HM, et al. Temporo-spatial IMRT optimization: Concepts, implementation and initial results. Phys Med Biol. 2005;50:2779–2798
  84. Li X, Zhang P, Mah D, et al. Novel lung IMRT planning algorithms with nonuniform dose delivery strategy to account for respiratory motion. Med Phys. 2006;33:3390–3398
  85. Mexner V, Wolthaus JW, van Herk M, et al. Effects of respiration-induced density variations on dose distributions in radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 2009;74:1266–1275
  86. Zhang P, Hugo GD, Yan D. Planning study comparison of real-time target tracking and four-dimensional inverse planning for managing patient respiratory motion. Int J Radiat Oncol Biol Phys. 2008;72:1221–1227
  87. Keall PJ, Joshi S, Vedam SS, et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys. 2005;32:942–951
  88. Löf J, Lind BK, Brahme A. An adaptive control algorithm for optimization of intensity modulated radiotherapy considering uncertainties in beam profiles, patient set-up and internal organ motion. Phys Med Biol. 1998;43:1605–1628
  89. Witte MG, van der Geer J, Schneider C. IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. Med Phys. 2007;34:3544–3555
  90. Ten Haken RK, Balter JM, Marsh LH, et al. Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors. Int J Radiat Oncol Biol Phys. 1997;38:613–617
  91. Guckenberger M, Krieger T, Richter A, et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol. 2009;91:288–295
  92. Kubo HD, Hill BC. Respiration gated radiotherapy treatment: A technical study. Phys Med Biol. 1996;41:83–91
  93. Shirato H, Shimizu S, Shimizu T, et al. Real-time tumour-tracking radiotherapy. Lancet. 1999;353:1331–1332
  94. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 1999;44:911–919
  95. Adler JR, Chang SD, Murphy MJ, et al. The Cyberknife: A frameless robotic system for radiosurgery. Stereotact Funct Neurosurg. 1997;69:124–128
  96. Casamassima F, Cavedon C, Francescon P, et al. Use of motion tracking in stereotactic body radiotherapy: Evaluation of uncertainty in off-target dose distribution and optimization strategies. Acta Oncol. 2006;45:943–947
  97. Korreman SS, Juhler-Nottrup T, Boyer AL. Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance. Radiother Oncol. 2008;86:61–68
  98. Lin T, Cervino LI, Tang X, et al. Fluoroscopic tumor tracking for image-guided lung cancer radiotherapy. Phys Med Biol. 2009;54:981–992
  99. Shirato H, Shimizu S, Kunieda T. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1187–1195
  100. Juhler Nottrup T, Korreman SS, Pedersen AN, et al. Intra- and interfraction breathing variations during curative radiotherapy for lung cancer. Radiother Oncol. 2007;84:40–48
  101. Chen QS, Weinhous MS, Deibel FC. Fluoroscopic study of tumor motion due to breathing: Facilitating precise radiation therapy for lung cancer patients. Med Phys. 2001;28:1850–1856
  102. Keall PJ, Kini VR, Vedam SS. Motion adaptive x-ray therapy: A feasibility study. Phys Med Biol. 2001;46:1–10
  103. Trofimov A, Vrancic C, Chan TC, et al. Tumor trailing strategy for intensity-modulated radiation therapy of moving targets. Med Phys. 2008;35:1718–1733
  104. Yan D, Wong J, Vicini F, et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys. 1997;38:197–206
  105. Brock KK, McShan DL, Ten Haken RK, et al. Inclusion of organ deformation in dose calculations. Med Phys. 2003;30:290–295
  106. Kessler ML. Image registration and data fusion in radiation therapy. Br J Radiol. 2006;79:S99–S108
  107. Unkelbach J, Oelfke U. Incorporating organ movements in inverse planning: Assessing dose uncertainties by Bayesian inference. Phys Med Biol. 2005;50:121–139
  108. Lam KL, Ten Haken RK, Litzenberg D, et al. An application of Bayesian statistical methods to adaptive radiotherapy. Phys Med Biol. 2005;50:3849–3858
  109. Yan D, Wong JW, Gustafson G, et al. A new model for “accept or reject” strategies in off-line and on-line megavoltage treatment evaluation. Int J Radiat Oncol Biol Phys. 1995;31:943–952
  110. Yan D, Jaffray DA, Wong JW. A model to accumulate fractionated dose in a deforming organ. Int J Radiat Oncol Biol Phys. 1999;44:665–675
  111. van Zwienen M, van Beek S, Belderbos J, et al. Anatomical changes during radiotherapy of lung cancer patients. Int J Radiat Oncol Biol Phys. 2008;72:S111
  112. Woodford C, Yartsev S, Dar ARV. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys. 2007;69:1316–1322
  113. Feng M, Kong FM, Gross M, et al. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2009;73:1228–1234
  114. Gillham C, Zips D, Ponisch F, et al. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?. Radiother Oncol. 2008;88:335–341
  115. Cohade C, Wahl RL. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med. 2003;33:228–237
  116. van Loon J, Grutters J, Wanders R, et al. Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: A prospective study. Eur J Cancer. 2009;45:588–595
  117. Kased N, Erasmus JJ, Komaki R, et al. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: A brief review. J Thorac Oncol. 2008;3:534–538
  118. Yamamoto Y, Nishiyama Y, Monden T, et al. Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2006;33:140–147
  119. Aerts HJ, Bosmans G, van Baardwijk AA, et al. Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: A prospective study. Int J Radiat Oncol Biol Phys. 2008;71:1402–1407
  120. De Ruysscher D, Houben A, Aerts HJ, et al. Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent radiation-induced lung toxicity (RILT): A prospective pilot study. Radiother Oncol. 2009;91:415–420
  121. Kong FM, Frey KA, Quint LE, et al. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with nonsmall-cell lung cancer. J Clin Oncol. 2007;25:3116–3123
  122. van Baardwijk A, Bosmans G, Dekker A, et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy (A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients). Radiother Oncol. 2007;82:145–152
  123. Erdi YE, Macapinlac H, Rosenzweig KE, et al. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med. 2000;27:861–866
  124. Yan D, Lockman D, Martinez A, et al. Computed tomography guided management of interfractional patient variation. Semin Radiat Oncol. 2005;15:168–179

 J-J.S. acknowledges financial support from industry (Elekta, Philips) and support from various public granting agencies for his research in image-guided radiotherapy.

 The authors' institute is a member of the Elekta Synergy Research.

PII: S1053-4296(09)00077-0

doi: 10.1016/j.semradonc.2009.11.003

Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 94-106 , April 2010

Article Tools

* Image Usage & Resolution